Host immunity during RSV pathogenesis

International Immunopharmacology

Volumn 8, Issue 10, 2008, Pages 1320-1329

  Bueno, Susan M ^a   González, Pablo A ^a   Pacheco, Rodrigo ^a   Leiva, Eduardo D ^a   Cautivo, Kelly M ^a   Tobar, Hugo E ^a   Mora, Jorge E ^a   Prado, Carolina E ^a   Zúñiga, Juan P ^a   Jiménez, Jorge ^a   Riedel, Claudia A ^b   Kalergis, Alexis M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Dendritic cells; Immune response; Immunopathology; Respiratory syncytial virus; T cells; Th 2 immune response

Indexed keywords

DOUBLE STRANDED RNA; EOTAXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; RESPIRATORY SYNCYTIAL VIRUS ANTIGEN; STAT1 PROTEIN; STAT2 PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CHILDHOOD DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; DRUG SAFETY; HEALTH ECONOMICS; HOSPITALIZATION; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH2 CELL; VIRUS IMMUNITY; VIRUS INACTIVATION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANTIGENS, VIRAL; CROSS INFECTION; DENDRITIC CELLS; HUMANS; IMMUNITY; IMMUNIZATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH2 CELLS; VIRUS INACTIVATION;

EID: 50949104385     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.03.012     Document Type: Article

References (101)

1. Mejias A., Chavez-Bueno S., Jafri H.S., and Ramilo O. Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J 24 (2005) S189-S196 discussion S96-7
2. Hacking D., and Hull J. Respiratory syncytial virus-viral biology and the host response. J Infect 45 (2002) 18-24
3. Harris J., and Werling D. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response. Cell Microbiol 5 (2003) 671-680
4. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 186 (1997) 421-432
5. Srikiatkhachorn A., and Braciale T.J. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J Virol 71 (1997) 678-685
6. Chang J., Srikiatkhachorn A., and Braciale T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J Immunol 167 (2001) 4254-4260
7. Braciale T.J. Respiratory syncytial virus and t cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2 (2005) 141-146
8. Beckham J.D., Cadena A., Lin J., Piedra P.A., Glezen W.P., Greenberg S.B., et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50 (2005) 322-330
9. Englund J.A., Piedra P.A., Jewell A., Patel K., Baxter B.B., and Whimbey E. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 34 (1996) 1649-1653
10. Harker J., Bukreyev A., Collins P.L., Wang B., Openshaw P.J.M., and Tregoning J.S. Virally delivered cytokines alter the immune response to future lung infections. J Virol (2007) 01544-07
11. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89 (1969) 422-434
12. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., and Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89 (1969) 405-421
13. Connors M., Giese N.A., Kulkarni A.B., Firestone C.Y., Morse III H.C., and Murphy B.R. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol 68 (1994) 5321-5325
14. Waris M.E., Tsou C., Erdman D.D., Zaki S.R., and Anderson L.J. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J Virol 70 (1996) 2852-2860
15. Moghaddam A., Olszewska W., Wang B., Tregoning J.S., Helson R., Sattentau Q.J., et al. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat Med 12 (2006) 905-907
16. Yoon J.S., Kim H.H., Lee Y., and Lee J.S. Cytokine induction by respiratory syncytial virus and adenovirus in bronchial epithelial cells. Pediatr Pulmonol 42 (2007) 277-282
17. Openshaw P.J., and Tregoning J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18 (2005) 541-555
18. Groskreutz D.J., Monick M.M., Powers L.S., Yarovinsky T.O., Look D.C., and Hunninghake G.W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 176 (2006) 1733-1740
19. Liu P., Jamaluddin M., Li K., Garofalo R., Casola A., and Brasier A. Retinoic acid-inducible gene I mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 81 (2007) 1401-1411
20. Janssen R., Pennings J., Hodemaekers H., Buisman A., van Oosten M., de Rond L., et al. Host transcription profiles upon primary respiratory syncytial virus infection. J Virol 81 (2007) 5958-5967
21. + T cell recruitment during respiratory syncytial virus infection. J Gen Virol 79 Pt 11 (1998) 2593-2601
22. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1 (2000) 398-401
23. Tulic M.K., Hurrelbrink R.J., Prele C.M., Laing I.A., Upham J.W., Le Souef P., et al. Polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 179 (2007) 132-140
24. Monick M.M., Yarovinsky T.O., Powers L.S., Butler N.S., Carter A.B., Gudmundsson G., et al. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 278 (2003) 53035-53044
25. Rudd B.D., Smit J.J., Flavell R.A., Alexopoulou L., Schaller M.A., Gruber A., et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 176 (2006) 1937-1942
26. Rudd B.D., Burstein E., Duckett C.S., Li X., and Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79 (2005) 3350-3357
27. Resch B., Gusenleitner W., and Mueller W.D. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatrica 96 (2007) 495-498
28. Stark J.M., Stark M.A., Colasurdo G.N., and LeVine A.M. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Virol 78 (2006) 829-838
29. Noah T.L., and Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265 (1993) L472-L478
30. Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 18 (1999) 115-122
31. Matthews S.P., Tregoning J.S., Coyle A.J., Hussell T., and Openshaw P.J. Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J Virol 79 (2005) 2050-2057
32. Culley F.J., Pennycook A.M., Tregoning J.S., Dodd J.S., Walzl G., Wells T.N., et al. Role of CCL5 (RANTES) in viral lung disease. J Virol 80 (2006) 8151-8157
33. Culley F.J., Pennycook A.M., Tregoning J.S., Hussell T., and Openshaw P.J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol 80 (2006) 4521-4527
34. Bermejo-Martin J.F., Garcia-Arevalo M.C., De Lejarazu R.O., Ardura J., Eiros J.M., Alonso A., et al. Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur Cytokine Netw 18 (2007) 162-167
35. Niimi K., Asano K., Shiraishi Y., Nakajima T., Wakaki M., Kagyo J., et al. TLR3-mediated synthesis and release of eotaxin-1/CCL11 from human bronchial smooth muscle cells stimulated with double-stranded RNA. J Immunol 178 (2007) 489-495
36. Haeberle H.A., Kuziel W.A., Dieterich H.J., Casola A., Gatalica Z., and Garofalo R.P. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol 75 (2001) 878-890
37. Tekkanat K.K., Maassab H., Miller A., Berlin A.A., Kunkel S.L., and Lukacs N.W. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur J Immunol 32 (2002) 3276-3284
38. Jafri H.S., Chavez-Bueno S., Mejias A., Gomez A.M., Rios A.M., Nassi S.S., et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189 (2004) 1856-1865
39. McNamara P.S., Flanagan B.F., Selby A.M., Hart C.A., and Smyth R.L. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23 (2004) 106-112
40. Grissell T.V., Powell H., Shafren D.R., Boyle M.J., Hensley M.J., Jones P.D., et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 172 (2005) 433-439
41. Elliott M.B., Tebbey P.W., Pryharski K.S., Scheuer C.A., Laughlin T.S., and Hancock G.E. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5). J Med Virol 73 (2004) 300-308
42. Garcia-Sastre A., and Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 (2006) 879-882
43. Horvath C.M., Stark G.R., Kerr I.M., and Darnell Jr. J.E. Interactions between STAT and non-STAT proteins in the interferon- stimulated gene factor 3 transcription complex. Mol Cell Biol 16 (1996) 6957-6964
44. Jewell N.A., Vaghefi N., Mertz S.E., Akter P., Peebles Jr. R.S., Bakaletz L.O., et al. Differential type I interferon induction by respiratory syncytial virus and influenza A virus in vivo. J Virol 81 (2007) 9790-9800
45. Durbin J.E., Johnson T.R., Durbin R.K., Mertz S.E., Morotti R.A., Peebles R.S., et al. The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168 (2002) 2944-2952
46. Johnson T.R., Mertz S.E., Gitiban N., Hammond S., LeGallo R., Durbin R.K., et al. Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol 174 (2005) 7234-7241
47. Schlender J., Bossert B., Buchholz U., and Conzelmann K.K. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 74 (2000) 8234-8242
48. Lo M.S., Brazas R.M., and Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79 (2005) 9315-9319
49. Elliott J., Lynch O.T., Suessmuth Y., Qian P., Boyd C.R., Burrows J.F., et al. Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J Virol 81 (2007) 3428-3436
50. Trombetta E.S., and Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23 (2005) 975-1028
51. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
52. Vermaelen K., and Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 172 (2005) 530-551
53. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 13 (2001) 114-119
54. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 5 (2004) 1219-1226
55. Steinman R.M., and Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311 (2006) 17-58
56. Lanzavecchia A., and Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 106 (2001) 263-266
57. Tobar J.A., Gonzalez P.A., and Kalergis A.M. Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol 173 (2004) 4058-4065
58. Bueno S.M., Tobar J.A., Iruretagoyena M.I., and Kalergis A.M. Molecular interactions between dendritic cells and Salmonella: escape from adaptive immunity and implications on pathogenesis. Crit Rev Immunol 25 (2005) 389-403
59. Weslow-Schmidt J.L., Jewell N.A., Mertz S.E., Simas J.P., Durbin J.E., and Flano E. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J Virol 81 (2007) 9778-9789
60. + T cell function during viral persistence. J Immunol 179 (2007) 141-153
61. Liu Y. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106 (2001) 259-262
62. Barchet W., Cella M., and Colonna M. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin Immunol 17 (2005) 253-261
63. Cella M., Facchetti F., Lanzavecchia A., and Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1 (2000) 305-310
64. de Graaff P.M.A., de Jong E.C., van Capel T.M., van Dijk M.E.A., Roholl P.J.M., Boes J., et al. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol 175 (2005) 5904-5911
65. Guerrero-Plata A., Casola A., Suarez G., Yu X., Spetch L., Peeples M.E., et al. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34 (2006) 320-329
66. Boogaard I., van Oosten M., van Rijt L.S., Muskens F., Kimman T.G., Lambrecht B.N., et al. Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells. Immunology 122 (2007) 65-72
67. Bartz H., Turkel O., Hoffjan S., Rothoeft T., Gonschorek A., and Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-g in naïve T cells. Immunology 109 (2003) 49-57
68. Schlender J., Hornung V., Finke S., Gunthner-Biller M., Marozin S., Brzozka K., et al. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79 (2005) 5507-5515
69. Wang H., Peters N., and Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 177 (2006) 6263-6270
70. + T cells. Immunol Rev 211 (2006) 81-92
71. Gill M.A., Palucka A.K., Barton T., Ghaffar F., Jafri H., Banchereau J., et al. Mobilization of plasmacytoid and myeloid dendritic cellsto mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis 1991 (2005) 1105-1115
72. Beyer M., Bartz H., Hörner K., Dotths S., Koerner-Rettberg C., and Schwarze J. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J allergy clin immunol 113 (2004) 127-133
73. Smit J.J., Rudd B.D., and Lukacs N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 203 (2006) 1153-1159
74. Wang H., Peters N., Laza-Stanca V., Nawroly N., Johnston S.L., and Schwarze J. Local CD11c+ MHC class II-precursors generate lung dendritic cells during respiratory viral infection, but are depleted in the process. J Immunol 177 (2006) 2536-2542
75. Singleton R., Etchart N., Hou S., and Hyland L. Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses. J Virol 77 (2003) 11303-11311
76. Hall C.B., Walsh E.E., Long C.E., and Schnabel K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163 (1991) 693-698
77. Hussell T., Spender L.C., Georgiou A., O'Garra A., and Openshaw P.J. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 77 Pt 10 (1996) 2447-2455
78. + T cells. J Virol 66 (1992) 7444-7451
79. + T cells. Immunity 15 (2001) 637-646
80. Roberts Jr. N.J., Prill A.H., and Mann T.N. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity. J Exp Med 163 (1986) 511-519
81. + T-cell memory in the respiratory tract. Nat Med. 8 (2002) 54-60
82. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 (2003) 223-246
83. Kalergis A.M., Goyarts E.C., Palmieri E., Honda S., Zhang W., and Nathenson S.G. A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I. J Immunol Methods 234 (2000) 61-70
84. Chang J., Choi S.Y., Jin H.T., Sung Y.C., and Braciale T.J. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol 172 (2004) 503-508
85. + T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology 352 (2006) 157-168
86. Schlender J., Walliser G., Fricke J., and Conzelmann K.K. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J Virol 76 (2002) 1163-1170
87. Chi B., Dickensheets H.L., Spann K.M., Alston M.A., Luongo C., Dumoutier L., et al. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 80 (2006) 5032-5040
88. Spann K.M., Tran K.C., Chi B., Rabin R.L., and Collins P.L. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 78 (2004) 4363-4369
89. Openshaw P.J., Culley F.J., and Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 20 Suppl 1 (2001) S27-S31
90. Polack F.P., Teng M.N., Collins P.L., Prince G.A., Exner M., Regele H., et al. A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med 196 (2002) 859-865
91. De Jesus N.H. Epidemics to eradication: the modern history of poliomyelitis. Virol J 4 (2007) 70
92. Youn H.J., Ko S.Y., Lee K.A., Ko H.J., Lee Y.S., Fujihashi K., et al. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25 (2007) 5189-5198
93. Tebbey P.W., Hagen M., and Hancock G.E. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med 188 (1998) 1967-1972
94. Openshaw P.J.M., Clarke S.L., and Record F.M. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol 4 (1992) 493-500
95. Hancock G.E., Speelman D.J., Heers K., Bortell E., Smith J., and Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol 70 (1996) 7783-7791
96. Tripp R.A., Jones L.P., Haynes L.M., Zheng H.Q., Murphy P.M., and Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2 (2001) 732-738
97. Harcourt J., Alvarez R., Jones L.P., Henderson C., Anderson L.J., and Tripp R.A. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol 176 (2006) 1600-1608
98. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33 (2006) 235-252
99. van Benten I.J., van Drunen C.M., Koevoet J.L., Koopman L.P., Hop W.C., Osterhaus A.D., et al. Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and non-atopic infants. J Med Virol 75 (2005) 348-357
100. Lindemans C.A., Kimpen J.L.L., Luijk B., Heidema J., Kanters D., van der Ent C.K., et al. Systemic eosinophil response induced by respiratory syncytial virus. Clin Exp Immunol 144 (2006) 409-417
101. Kristjansson S., Bjarnarson S.P., Wennergren G., Palsdottir A.H., Arnadottir T., Haraldsson A., et al. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116 (2005) 805-811